Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Cyclacel Pharmaceuti (CYCC)

Cyclacel Pharmaceuti (CYCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd. GlobeNewswire - Fri Sep 12, 2025

Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.) Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd....

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd. GlobeNewswire - Fri Sep 12, 2025

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the “Company”), a company engaged in diversified industries,...

CYCCP : 5.05 (-4.36%)
BGMS : 0.8600 (-3.44%)
BGMSP : 2.8100 (-6.33%)
CYCC : 6.37 (-5.98%)
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update GlobeNewswire - Wed Aug 13, 2025

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update GlobeNewswire - Wed Aug 13, 2025

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB GlobeNewswire - Mon Aug 4, 2025

         - Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals,...

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB GlobeNewswire - Mon Aug 4, 2025

         - Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE...

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY GlobeNewswire - Wed Jul 16, 2025

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a...

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER GlobeNewswire - Mon Jul 7, 2025

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT GlobeNewswire - Mon Jul 7, 2025

Kuala Lumpur, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a...

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT GlobeNewswire - Mon Jul 7, 2025

CYCCP : 5.05 (-4.36%)
CYCC : 6.37 (-5.98%)

Barchart Exclusives

This Is What Investors Should Watch Before Buying PANW Stock. Most Will Ignore It on September 1. Barchart - 33 minutes ago
Palo Alto Networks heads into earnings with surging expectations, but investors may need more than strong headline growth to justify the stock's enormous rally. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.